Marker Therapeutics, Inc. (MRKR)
Nasdaq: MRKR · CIK 0001094038 · United States
Every official Marker Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open MRKR filings
Marker Therapeutics, Inc. documents
- Marker Therapeutics, Inc. 10-K 2026MRKR 10-K 2026: annual report for fiscal 2026
- Marker Therapeutics, Inc. 10-K 2025MRKR 10-K 2025: annual report for fiscal 2025
- Marker Therapeutics, Inc. 10-K 2024MRKR 10-K 2024: annual report for fiscal 2024
- Marker Therapeutics, Inc. 10-K 2023MRKR 10-K 2023: annual report for fiscal 2023
- Marker Therapeutics, Inc. 10-K 2022MRKR 10-K 2022: annual report for fiscal 2022
- Marker Therapeutics, Inc. 10-Q 2026MRKR 10-Q 2026: quarterly report for fiscal 2026
- Marker Therapeutics, Inc. 10-Q 2025MRKR 10-Q 2025: quarterly report for fiscal 2025
- Marker Therapeutics, Inc. 10-Q 2024MRKR 10-Q 2024: quarterly report for fiscal 2024
- Marker Therapeutics, Inc. 10-Q 2023MRKR 10-Q 2023: quarterly report for fiscal 2023
- Marker Therapeutics, Inc. 10-Q 2022MRKR 10-Q 2022: quarterly report for fiscal 2022
- Marker Therapeutics, Inc. 8-K 2026MRKR 8-K 2026: current report for fiscal 2026
- Marker Therapeutics, Inc. 8-K 2025MRKR 8-K 2025: current report for fiscal 2025
- Marker Therapeutics, Inc. 8-K 2024MRKR 8-K 2024: current report for fiscal 2024
- Marker Therapeutics, Inc. 8-K 2023MRKR 8-K 2023: current report for fiscal 2023
- Marker Therapeutics, Inc. 8-K 2022MRKR 8-K 2022: current report for fiscal 2022
- Marker Therapeutics, Inc. DEF 14A 2026MRKR DEF 14A 2026: proxy statement for fiscal 2026
- Marker Therapeutics, Inc. DEF 14A 2025MRKR DEF 14A 2025: proxy statement for fiscal 2025
- Marker Therapeutics, Inc. DEF 14A 2024MRKR DEF 14A 2024: proxy statement for fiscal 2024
- Marker Therapeutics, Inc. DEF 14A 2023MRKR DEF 14A 2023: proxy statement for fiscal 2023
- Marker Therapeutics, Inc. DEF 14A 2022MRKR DEF 14A 2022: proxy statement for fiscal 2022
- Marker Therapeutics, Inc. Form 4 2026MRKR Form 4 2026: insider trading filing for fiscal 2026
- Marker Therapeutics, Inc. Form 4 2025MRKR Form 4 2025: insider trading filing for fiscal 2025
- Marker Therapeutics, Inc. Form 4 2024MRKR Form 4 2024: insider trading filing for fiscal 2024
- Marker Therapeutics, Inc. Form 4 2023MRKR Form 4 2023: insider trading filing for fiscal 2023
- Marker Therapeutics, Inc. Form 4 2022MRKR Form 4 2022: insider trading filing for fiscal 2022
- Marker Therapeutics, Inc. S-1 2026MRKR S-1 2026: registration statement for fiscal 2026
- Marker Therapeutics, Inc. S-1 2025MRKR S-1 2025: registration statement for fiscal 2025
- Marker Therapeutics, Inc. S-1 2024MRKR S-1 2024: registration statement for fiscal 2024
- Marker Therapeutics, Inc. S-1 2023MRKR S-1 2023: registration statement for fiscal 2023
- Marker Therapeutics, Inc. S-1 2022MRKR S-1 2022: registration statement for fiscal 2022
- Marker Therapeutics, Inc. 13F 2026MRKR 13F 2026: institutional holdings for fiscal 2026
- Marker Therapeutics, Inc. 13F 2025MRKR 13F 2025: institutional holdings for fiscal 2025
- Marker Therapeutics, Inc. 13F 2024MRKR 13F 2024: institutional holdings for fiscal 2024
- Marker Therapeutics, Inc. 13F 2023MRKR 13F 2023: institutional holdings for fiscal 2023
- Marker Therapeutics, Inc. 13F 2022MRKR 13F 2022: institutional holdings for fiscal 2022
More companies